Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?

@article{Sanacora2015KetaminePP,
  title={Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?},
  author={Gerard Sanacora and Alan F. Schatzberg},
  journal={Neuropsychopharmacology},
  year={2015},
  volume={40},
  pages={259-267}
}
Large ‘real world’ studies demonstrating the limited effectiveness and slow onset of clinical response associated with our existing antidepressant medications has highlighted the need for the development of new therapeutic strategies for major depression and other mood disorders. Yet, despite intense research efforts, the field has had little success in developing antidepressant treatments with fundamentally novel mechanisms of action over the past six decades, leaving the field wary and… CONTINUE READING

1 Figure or Table

Connections & Topics

Mentioned Connections BETA
real world’ studies demonstrating the limited effectiveness and slow onset of clinical response associated with our existing antidepressant medications has highlighted the need for the development of new therapeutic strategies for major depression and other mood disorders .
real world’ studies demonstrating the limited effectiveness and slow onset of clinical response associated with our existing antidepressant medications has highlighted the need for the development of new therapeutic strategies for major depression and other mood disorders .
real world’ studies demonstrating the limited effectiveness and slow onset of clinical response associated with our existing antidepressant medications has highlighted the need for the development of new therapeutic strategies for major depression and other mood disorders .
All Topics